NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Mental Health Weekly Digest

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Obesity Therapy



Melanin-concentrating hormone receptor antagonists offer new obesity therapies



August 28th, 2006

Recent advances in the discovery of melanin-concentrating hormone receptor antagonists have brought effective obesity treatments.

"In recent years, obesity therapy has become a major focus of pharmaceutical research. The worldwide market for obesity therapeutics has increased dramatically over the past decade, and obesity has been linked with numerous co-morbidities," a review in the United States reports.

"The discovery of the role of melanin-concentrating hormone (MCH) in the regulation of energy homeostasis has attracted the interest of several research groups worldwide. In conjunction with energy balance, a growing body of evidence suggests that...


Source: Mental Health Weekly Digest (2006-08-28)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login